DEXILANT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dexilant, and what generic alternatives are available?
Dexilant is a drug marketed by Takeda Pharms Usa and is included in two NDAs. There are twelve patents protecting this drug and one Paragraph IV challenge.
This drug has one hundred and twenty patent family members in thirty-one countries.
The generic ingredient in DEXILANT is dexlansoprazole. There are seventeen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dexlansoprazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dexilant
A generic version of DEXILANT was approved as dexlansoprazole by ENDO OPERATIONS on April 19th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEXILANT?
- What are the global sales for DEXILANT?
- What is Average Wholesale Price for DEXILANT?
Summary for DEXILANT
International Patents: | 120 |
US Patents: | 10 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 61 |
Clinical Trials: | 31 |
Patent Applications: | 515 |
Drug Prices: | Drug price information for DEXILANT |
Drug Sales Revenues: | Drug sales revenues for DEXILANT |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for DEXILANT |
What excipients (inactive ingredients) are in DEXILANT? | DEXILANT excipients list |
DailyMed Link: | DEXILANT at DailyMed |
Recent Clinical Trials for DEXILANT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Karachi | Phase 1 |
SAMI Pharmaceutical, Karachi Pakistan | Phase 1 |
Taipei Veterans General Hospital, Taiwan | N/A |
Pharmacology for DEXILANT
Drug Class | Proton Pump Inhibitor |
Mechanism of Action | Proton Pump Inhibitors |
Paragraph IV (Patent) Challenges for DEXILANT
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
DEXILANT | Delayed-release Capsules | dexlansoprazole | 30 mg | 022287 | 1 | 2010-11-30 |
US Patents and Regulatory Information for DEXILANT
DEXILANT is protected by seven US patents.
Patents protecting DEXILANT
Multiple PPI dosage form
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Controlled release preparation
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Controlled release preparation
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Method for producing granules
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Method for producing granules
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: USE OF DEXLANSOPRAZOLE IN PATIENTS TAKING CLOPIDOGREL WITHOUT MEANINGFUL CYP2C19 INTERACTIONS
Multiple PPI dosage form
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-001 | Jan 30, 2009 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-002 | Jan 30, 2009 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Takeda Pharms Usa | DEXILANT SOLUTAB | dexlansoprazole | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL | 208056-001 | Jan 26, 2016 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-001 | Jan 30, 2009 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DEXILANT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-001 | Jan 30, 2009 | ⤷ Sign Up | ⤷ Sign Up |
Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-002 | Jan 30, 2009 | ⤷ Sign Up | ⤷ Sign Up |
Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-002 | Jan 30, 2009 | ⤷ Sign Up | ⤷ Sign Up |
Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-002 | Jan 30, 2009 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DEXILANT
See the table below for patents covering DEXILANT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 4536905 | ⤷ Sign Up | |
China | 101884629 | Controlled release preparation | ⤷ Sign Up |
European Patent Office | 0237200 | USE OF BASIC INORGANIC SALTS OF MAGNESIUM OR CALCIUM FOR THE STABILISATION OF BENZIMIDAZOLE DERIVATIVES | ⤷ Sign Up |
Mexico | PA01012642 | CRISTAL DE UN COMPUESTO DE BENZIMIDAZOL. (BENZIMIDAZOLE COMPOUND CRYSTAL.) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for DEXILANT
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1129088 | PA2014014 | Lithuania | ⤷ Sign Up | PRODUCT NAME: DEXLANSOPRAZOLUM; REGISTRATION NO/DATE: LT/1/13/3415/001 - LT/1/13/3415/004, 2013 10 31 LT/1/13/3416/001 - LT/1/13/3416/004 20131031 |
1129088 | 1490004-7 | Sweden | ⤷ Sign Up | PRODUCT NAME: DEXLANSOPRAZOL; REG. NO/DATE: 47912, 47913, 47914 20130919 |
1129088 | C01129088/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: DEXLANSOPARAZOL; REGISTRATION NO/DATE: SWISSMEDIC 62993 09.05.2014 |
1129088 | 2014/008 | Ireland | ⤷ Sign Up | PRODUCT NAME: DEXLANSOPRAZOLE OR A SALT THEREOF; NAT REGISTRATION NO/DATE: PA1864/001/001-002;PA1864/002/001-002 20131125; FIRST REGISTRATION NO/DATE: 47911 47912 47913 47914 20130919 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |